Klose R, Krzywinska E, Castells M, Gotthardt D, Putz E, Kantari Mimoun C, et al. Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexia. Nat Commun. 2016;7:12528 pubmed 出版商

Bo Q, Sun X, Liu J, Sui X, Li G. Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma. Oncol Lett. 2015;10:1979-1984 pubmed

Lin J, Maimaitiyiming A, Chen S, Xiao M, Xian Z. Hypoxia-induced miR-27 and miR-195 regulate ATP consumption, viability, and metabolism of rat cardiomyocytes by targeting PPARγ and FASN expression. Aging (Albany NY). 2021;13:10158-10174 pubmed 出版商

Liu E, Wang X, Li X, Tian P, Xu H, Li Z, et al. Co-exposure to multi-walled carbon nanotube and lead ions aggravates hepatotoxicity of nonalcoholic fatty liver via inhibiting AMPK/PPARγ pathway. Aging (Albany NY). 2020;12:14189-14204 pubmed 出版商

Kureel S, Mogha P, Khadpekar A, Kumar V, Joshi R, Das S, et al. Soft substrate maintains proliferative and adipogenic differentiation potential of human mesenchymal stem cells on long-term expansion by delaying senescence. Biol Open. 2019;8: pubmed 出版商

Biernacki M, Łuczaj W, Jarocka Karpowicz I, Ambrożewicz E, Toczek M, Skrzydlewska E. The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension. Molecules. 2018;23: pubmed 出版商

Vasaturo M, Fiengo L, De Tommasi N, Sabatino L, Ziccardi P, Colantuoni V, et al. A compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPARγ partial agonist with anti-proliferative ability. Sci Rep. 2017;7:41273 pubmed 出版商